Regulatory News:

Following Arkema's (Paris:AKE) Board of Directors’ meeting held on 29 July 2020 to approve the Group's consolidated financial statements for the first half of 2020, Chairman and CEO Thierry Le Hénaff said:

“The second quarter was marked by the context of Covid-19 and the lockdown measures imposed in many countries. Arkema’s sales were clearly impacted by this situation, but the decline was contained thanks to the Group’s worldwide positioning and the diversity of its end markets. The Group demonstrated its resilience in this unprecedented context, thereby validating its strategy of refocusing its business portfolio toward specialties.

I am very pleased with the mobilization and reactivity of the Group’s employees throughout this period. Arkema’s teams worked hard, focusing on both the short- and mid-term.

For the short-term, we concentrated on the elements that are within our control, putting in place decisive initiatives to reduce costs and tightly control working capital and capital expenditure. This enabled us to deliver a robust financial performance in the second quarter and achieve a high level of cash generation despite the challenging operating environment. In the second half of the year, while expecting to see a gradual improvement in end markets, Arkema will continue its cost-saving and cash-generation efforts in an environment still marked by low visibility with regards to the evolution and effects of the pandemic.

At the same time, the Group confirmed its determination to implement the roadmap announced at the Investor Day on 2 April. The finalization of the divestment of the Functional Polyolefins business in early June, Bostik’s acquisition of Fixatti and the start of strategic reviews regarding the evolution of the portfolio in Intermediates marked the launch of the M&A phase. Our organic growth ambitions have been supported by the partnership with Nutrien, the progress made in the construction of our bio-based polymer plant in Singapore despite the Covid-19 pandemic, and the acceleration of sustainable innovation projects in Specialty Materials.”

KEY FIGURES FOR SECOND-QUARTER 2020

(In millions of euros)  

Q2'20

 

Q2'19

 

YoY change

Sales  

1,902

 

2,254

 

-15.6%

EBITDA  

  286

 

  407

 

-29.7%

Specialty Materials (1)  

  233

 

  304

 

-23.4%

Intermediates  

  66

 

  127

 

-48.0%

Corporate  

-13

 

-24

 
EBITDA margin  

15.0%

 

18.1%

  
Recurring operating income (REBIT)  

 144

 

 278

 

-48.2%

REBIT margin  

7.6%

 

12.3%

  
Adjusted net income  

  90

 

  192

 

-53.1%

Adjusted net income per share (in €)  

1.18

 

2.52

 

-53.2%

Free cash flow  

288

 

90

  
Net debt including hybrid bonds  

2,134

 

2,008

  
€2,331m as of 31/12/2019     

SECOND-QUARTER 2020 BUSINESS PERFORMANCE

Sales amounted to €1,902 million, down 15.6% year on year, and down 18.1% at constant scope and currency. Volumes declined 12.2%, impacted by the lockdown measures imposed in many countries during the quarter. The transportation, industrial and construction sectors in the United States, Southeast Asia and Europe were more particularly affected, but the decline in these sectors was partly offset by good demand in the packaging, nutrition and hygiene markets. The construction market improved in June in Europe and the United States. Moreover, the Group benefitted from the diversity of its end markets and geographic footprint. The price effect was a negative 5.9%, mainly reflecting more challenging market conditions for Intermediates in a context of lower demand, offset by resilient prices in Adhesive Solutions and Advanced Materials. The integration of ArrMaz in Advanced Materials, Prochimir and LIP in Adhesive Solutions and Lambson in Coating Solutions, as well as the divestment of the Functional Polyolefins business at 1 June, resulted in a 2.9% positive scope effect. The currency effect was limited to a negative 0.4%. In second-quarter 2020, Specialty Materials (1) accounted for 80% of total Group sales (78% in Q2 2019).

Group EBITDA came in at €286 million (€407 million in Q2 2019), reflecting the impact of much lower demand. Advanced Materials held up well in this context thanks to the good performance of certain end markets such as nutrition, the benefits of innovation in niche applications used in the fight against the virus, as well as the contribution of ArrMaz. Adhesive Solutions logically suffered in April and May from the construction market's slump in Europe and the United States, but delivered a much better performance in June as lockdowns were lifted in a number of countries that are important for the Group. At 15.0%, EBITDA margin remained solid, notably supported by the solid performance of Advanced Materials, which delivered a 20% EBITDA margin, by the improvement of Adhesive Solutions in June, and by the initiatives to reduce fixed costs.

Recurring operating income (REBIT) came to €144 million. This amount includes €142 million in recurring depreciation and amortization, €13 million higher than in second-quarter 2019 due essentially to the start-up of production units in 2019 and early 2020, and the integration of acquisitions. REBIT margin stood at 7.6%.

Adjusted net income came in at €90 million, representing €1.18 per share. In the first half, excluding exceptional items, the tax rate came in at around 22% of recurring operating income.

CASH FLOW AND NET DEBT AT 30 JUNE 2020

Free cash flow amounted to €288 million, a record high for a second quarter, versus €90 million in second-quarter 2019. It includes a €105 million cash inflow related to the change in working capital during the period (compared with a €77 million cash outflow in Q2 2019), reflecting strict management of inventory and receivables in a context of lower sales and costs for certain raw materials. At 30 June 2020, the ratio of working capital to annualized quarterly sales was 16.5%, close to the year-earlier figure of 16.0%.

Free cash flow for second-quarter 2020 also includes non-recurring tax savings linked to the use of tax losses for an amount of €55 million.

Capital expenditure totaled €123 million for the period (€124 million in Q2 2019), of which €78 million was recurring and €44 million exceptional. The exceptional capex related to the polyamides project in Asia and the partnership with Nutrien announced in June for the long-term supply of anhydrous hydrogen fluoride in the US. As stated in the Group’s first-quarter 2020 results release, recurring and exceptional capital expenditure for the full year is expected to total around €600 million, €100 million lower than the amount originally planned for 2020.

Cash flows from portfolio management operations represented a net inflow of €242 million, essentially corresponding to the divestment of the Functional Polyolefins business, finalized on 1 June.

Including €1.0 billion in hybrid bonds, net debt stood at €2.13 billion at end-June 2020 versus €2.48 billion at 31 March 2020. This figure includes the €2.20 per-share dividend payment for a total payout of €168 million, €21 million in share buyback costs, and €7 million in proceeds from the capital increase reserved to employees. The ratio of net debt (including hybrid bonds) to last-twelve-months EBITDA remained well contained, at 1.7x.

SECOND-QUARTER 2020 PERFORMANCE BY SEGMENT

ADHESIVE SOLUTIONS (24% OF TOTAL GROUP SALES)

(In millions of euros)  

Q2'20

 

Q2'19

 

YoY change

Sales  

453

 

520

 

-12.9%

EBITDA  

50

 

71

 

-29.6%

EBITDA margin  

11.0%

 

13.7%

  
Recurring operating income (REBIT)  

35

 

55

 

-36.4%

REBIT margin  

7.7%

 

10.6%

  

Sales for the Adhesive Solutions segment totaled €453 million, down 12.9% year on year. Despite the packaging and hygiene markets holding firm, volumes fell by 13.2%, impacted by the sharp slowdown in demand in the construction, transportation and industrial sectors. The improvement in the construction and DIY markets seen in Europe and the United States in June helped to mitigate the overall second-quarter decrease in volumes, but industrial markets remained mixed. Prices held up well during the period, down by just 0.9%, reflecting, in the continuity of the first quarter, the measures taken by the Group in 2019 to optimize the product mix. The scope effect was a positive 2.7% and corresponds to the integration of LIP and Prochimir. The negative 1.5% foreign exchange impact mainly reflects the devaluation of emerging currencies.

The segment’s EBITDA totaled €50 million, impacted in April and May by the sharp contraction in volumes in the construction market, and also reflecting weak demand in the industrial assembly sector. Bostik’s performance picked up sharply in June thanks to the rebound seen in the construction and DIY markets. The challenging macro-economic environment overshadowed the benefits of operational excellence and fixed cost savings initiatives announced in May, as well as the favorable impact of certain raw materials. The segment’s performance also includes the contributions of LIP and Prochimir. EBITDA margin stood at 11.0%, temporarily down on second-quarter 2019.

ADVANCED MATERIALS (33% OF TOTAL GROUP SALES)

(In millions of euros)  

Q2'20

 

Q2'19

 

YoY change

Sales  

628

 

650

 

-3.4%

EBITDA  

124

 

142

 

-12.7%

EBITDA margin  

19.7%

 

21.8%

  
Recurring operating income (REBIT)  

61

 

87

 

-29.9%

REBIT margin  

9.7%

 

13.4%

  

Sales for the Advanced Materials segment were slightly down 3.4% to €628 million. Volumes fell 11.5% year on year due to the impact of the Covid-19 crisis, which weighed strongly on demand for High Performance Polymers. In the continuity of the first quarter, the decline was particularly significant in the transportation, consumer electronics, oil & gas and sports sectors, overshadowing the good performance of the nutrition market and certain niche applications used in the fight against the virus. The price effect was limited at a negative 2.0%, while the consolidation of ArrMaz added 10.1% to the segment’s sales, driven by favorable end-markets such as crop nutrition.

At €124 million, the segment’s EBITDA was 12.7% lower than last year. This decrease reflects the sharp drop in volumes, notably for High Performance Polymers, partly offset by the good resistance of Performance Additives, which benefitted from the consolidation of ArrMaz. EBITDA margin remained at a high level at 19.7% (21.8% in second-quarter 2019), benefitting from a good product mix, the favorable evolution of certain raw materials, and the reduction in fixed costs.

COATING SOLUTIONS (23% OF TOTAL GROUP SALES)

(In millions of euros)  

Q2'20

 

Q2'19

 

YoY change

Sales  

436

 

575

 

-24.2%

EBITDA  

59

 

91

 

-35.2%

EBITDA margin  

13.5%

 

15.8%

  
Recurring operating income (REBIT)  

28

 

62

 

-54.8%

REBIT margin  

6.4%

 

10.8%

  

Sales for the Coating Solutions segment dropped to €436 million. The 15.8% decline in volumes was linked to weak demand in construction, paints and in some industrial markets. The price effect was a negative 9.5%, stemming mainly from lower propylene prices. The scope effect of +1.2% was linked to the integration of Lambson, and the currency effect was very limited at a negative 0.1%.

At €59 million, the segment’s EBITDA was down sharply on the excellent performance achieved in second‑quarter 2019 (€91 million), but nevertheless benefitted from the improvement of the decorative paints market in June. In the context of much lower volumes, the segment’s EBITDA margin held up well, coming in at 13.5% (15.8% in second-quarter 2019), thanks in particular to the benefits of the integration between upstream and downstream activities.

INTERMEDIATES (20% OF TOTAL GROUP SALES)

(In millions of euros)

 

Q2'20

 

Q2'19

 

YoY change

Sales

 

379

 

502

 

-24.5%

EBITDA  

66

 

127

 

-48.0%

EBITDA margin  

17.4%

 

25.3%

  
Recurring operating income (REBIT)  

35

 

99

 

-64.6%

REBIT margin  

9.2%

 

19.7%

  

At €379 million, sales for the Intermediates segment were down 24.5% compared with the second quarter of 2019. The price effect was a negative 12.3%, essentially due to the challenging market conditions in Fluorogases and lower propylene prices. Volumes declined by 8.1%, mainly reflecting the slowdown in the construction and automotive sectors, while demand in the niche market for PMMA protective sheets remained strong, as in the first quarter. The scope effect was a negative 4.2%, corresponding to the divestment of the Functional Polyolefins business finalized on 1 June 2020. The currency effect was limited, at a positive 0.1%.

In this context of strong declines in volumes and prices, the segment’s EBITDA was significantly lower than in second-quarter 2019, totaling €66 million. Furthermore, the performance of Fluorogases was impacted by illegal HFC imports into Europe, although the effect of this eased towards the end of the period. EBITDA margin contracted to 17.4%.

KEY FIGURES FOR FIRST-HALF 2020

(In millions of euros)  

H1'20

 

H1'19

 

YoY change

Sales  

3,990

 

4,469

 

-10.7%

EBITDA  

  586

 

  777

 

-24.6%

Specialty Materials  

  489

 

  596

 

-18.0%

Intermediates  

  134

 

  230

 

-41.7%

Corporate  

-37

 

-49

 
EBITDA margin  

14.7%

 

17.4%

  
Recurring operating income (REBIT)  

 304

 

 525

 

-42.1%

REBIT margin  

7.6%

 

11.7%

  
Adjusted net income  

  190

 

  357

 

-46.8%

Adjusted net income per share (in €)  

2.49

 

4.68

 

-46.8%

Free Cash Flow  

250

 

163

  

SUBSEQUENT EVENTS

On 20 July 2020, Arkema announced its proposed acquisition of Fixatti, a company specialized in high‑performance thermobonding adhesive powders reporting annual sales of around €55 million. This acquisition will enable Bostik to strengthen its global offering of hotmelt adhesive solutions for niche industrial applications in the construction, technical coating, battery, automotive, and textile printing markets. The deal is expected to close in the fourth quarter of 2020, subject to approval by the antitrust authorities in the relevant countries.

On 29 July 2020, the Group secured refinancing for its €900 million credit facility maturing on 29 October 2021 by setting up a new multi-currency syndicated credit facility whose amount was raised to €1 billion. This new facility has an initial term of three years with a maturity date of 29 July 2023 and two one-year extension options exercisable, subject to the lenders' approval, at the end of the first and the second year. It is intended to finance the Group’s general corporate needs and to serve as a back-up facility for the Negotiable European Commercial Paper program.

OUTLOOK FOR 2020

Based on the progressive lifting of lockdown measures in some important countries for the Group, Arkema expects that demand will continue to improve gradually in the second part of the year, while remaining below last year’s level. The pace and strength of this improvement are still uncertain, dependent on the evolution of the pandemic, and will vary between end-markets and geographies. Arkema estimates at this stage that sales in the third quarter will decline by around 10% year-on-year at constant scope and currency, representing a clear improvement compared to the decline of around 20% recorded in the second quarter.

In this context, Arkema will focus its efforts on the elements that are within its control, in particular costs, capital expenditure and working capital in order to maintain a strong level of liquidity. The Group thus confirms it is on track to reduce in 2020 its fixed costs by €50 million compared to 2019 and to reduce capital expenditure by €100 million compared to the level originally planned. Its innovation efforts in Specialty Materials will be preserved in order to meet its customers’ numerous technological and sustainable development opportunities. Thanks to those initiatives, and on the back of its solid performance in the second quarter given the current environment, the Group remains very confident in its ability to deal with this unprecedented crisis, drawing also on its balanced geographic exposure, diversified end markets and strong balance sheet.

Finally, Arkema will continue its acquisition strategy, the roll-out of its major organic growth projects, as well as its strategic review for Intermediates, in line with its ambition to become a pure Specialty Materials player by 2024.

Further details concerning the Group's second-quarter 2020 results are provided in the "Second-quarter 2020 results" presentation and the Factsheet, both available on Arkema's website at www.finance.arkema.com.

REGULATED INFORMATION

The half-year financial report at 30 June 2020 is available on the Group’s website (www.arkema.com) under Finance / Financials / Financial results.

FINANCIAL CALENDAR

5 November 2020

25 February 2021

 

Publication of third-quarter 2020 results

Publication of full-year 2020 results

Building on its unique set of expertise in materials science, Arkema offers a world-leading technology portfolio to address ever-growing demand for new and sustainable materials. With the ambition to become in 2024 a pure player in Specialty Materials, the Group is structured into three complementary, resilient and highly innovative segments dedicated to Specialty Materials – Adhesive Solutions, Advanced Materials and Coating Solutions – accounting for some 80% of Group sales, and a well-positioned and competitive Intermediates segment. Arkema offers cutting-edge technological solutions to meet the challenges of, inter alia, new energies, access to water, recycling, urbanization and mobility, and fosters a permanent dialogue with all its stakeholders. The Group reported sales of €8.7 billion in 2019, and operates in some 55 countries with 20,500 employees worldwide. www.arkema.com

DISCLAIMER

The information disclosed in this press release may contain forward-looking statements with respect to the financial position, results of operations, business and strategy of Arkema.

In the current context, where the Covid-19 epidemic continues to spread across the world, and the evolution of the situation as well as the magnitude of its impacts on the global economy are highly uncertain, the retained assumptions and forward-looking statements could ultimately prove inaccurate.

Such statements are based on management's current views and assumptions that could ultimately prove inaccurate and are subject to risk factors such as (but not limited to) changes in raw materials prices, currency fluctuations, the pace at which cost-reduction projects are implemented, developments in the Covid-19 situation, and changes in general economic and financial conditions. Arkema does not assume any liability to update such forward-looking statements whether as a result of any new information or any unexpected event or otherwise. Further information on factors which could affect Arkema's financial results is provided in the documents filed with the French Autorité des marchés financiers.

Balance sheet, income statement and cash flow statement data, as well as data relating to the statement of changes in shareholders' equity and information by segment included in this press release are extracted from the condensed consolidated financial statements at 30 June 2020 closed by Arkema’s Board of Directors on 29 July 2020. Quarterly financial information is not audited.

Information by segment is presented in accordance with Arkema's internal reporting system used by management.

Details of the main alternative performance indicators used by the Group are provided in the tables appended to this press release. For the purpose of analyzing its results and defining its targets, the Group also uses EBITDA margin, which corresponds to EBITDA expressed as a percentage of sales, EBITDA equaling recurring operating income (REBIT) plus recurring depreciation and amortization of tangible and intangible assets, as well as REBIT margin, which corresponds to recurring operating income (REBIT) expressed as a percentage of sales.

For the purpose of tracking changes in its results, and particularly its sales figures, the Group analyzes the following effects (unaudited analyses):

  • scope effect: the impact of changes in the Group’s scope of consolidation, which arise from acquisitions and divestments of entire businesses or as a result of the first-time consolidation or deconsolidation of entities. Increases or reductions in capacity are not included in the scope effect;
  • currency effect: the mechanical impact of consolidating accounts denominated in currencies other than the euro at different exchange rates from one period to another. The currency effect is calculated by applying the foreign exchange rates of the prior period to the figures for the period under review;
  • price effect: the impact of changes in average selling prices is estimated by comparing the weighted average net unit selling price of a range of related products in the period under review with their weighted average net unit selling price in the prior period, multiplied, in both cases, by the volumes sold in the period under review;
  • volume effect: the impact of changes in volumes is estimated by comparing the quantities delivered in the period under review with the quantities delivered in the prior period, multiplied, in both cases, by the weighted average net unit selling price in the prior period.

_______________
1
Specialty Materials include the three following segments: Adhesive Solutions, Advanced Materials and Coating Solutions

ARKEMA Financial Statements

Consolidated financial statements - At the end of June 2020

Half-year information is subject to a limited review by auditors.
Consolidated financial statements as of December 2019 have been audited.

CONSOLIDATED INCOME STATEMENT
             
   

2nd quarter 2020

 

End of June 2020

 

2nd quarter 2019

 

End of June 2019

(In millions of euros)     
             
      
Sales  

1.902

 

3.990

 

2.254

 

4.469

      
Operating expenses  

(1.539)

 

(3.211)

 

(1.731)

 

(3.456)

Research and development expenses  

(56)

 

(120)

 

(61)

 

(123)

Selling and administrative expenses  

(178)

 

(384)

 

(194)

 

(384)

Other income and expenses  

107

 

93

 

(11)

 

(23)

Operating income  

236

 

368

 

257

 

483

Equity in income of affiliates  

1

 

(1)

 

0

 

(1)

Financial result  

(22)

 

(45)

 

(33)

 

(60)

Income taxes  

(96)

 

(124)

 

(46)

 

(95)

Net income  

119

 

198

 

178

 

327

Of which non-controlling interests  

0

 

1

 

2

 

4

Net income - Group share  

119

 

197

 

176

 

323

Earnings per share (amount in euros)  

1.56

 

2.58

 

1.82

 

3.75

Diluted earnings per share (amount in euros)  

1.55

 

2.57

 

1.81

 

3.73

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
                
   

2nd quarter 2020

 

End of June 2020

 

2nd quarter 2019

 

End of June 2019

(In millions of euros)     
              
Net income  

119

 

198

 

178

 

327

Hedging adjustments  

15

 

8

 

2

 

(1)

Other items  

-

 

-

 

1

 

1

Deferred taxes on hedging adjustments and other items  

-

 

-

 

-

 

-

Change in translation adjustments  

(53)

 

(36)

 

(37)

 

14

Other recyclable comprehensive income   

(38)

 

(28)

 

(34)

 

14

Actuarial gains and losses  

(14)

 

(38)

 

(54)

 

(33)

Deferred taxes on actuarial gains and losses  

2

 

10

 

10

 

5

Other non-recyclable comprehensive income   

(12)

 

(28)

 

(44)

 

(28)

Total income and expenses recognized directly in equity  

(50)

 

(56)

 

(78)

 

(14)

Comprehensive income  

69

 

142

 

100

 

313

Of which: non-controlling interest  

(1)

 

1

 

-

 

4

Comprehensive income - Group share  

70

 

141

 

100

 

309

INFORMATION BY SEGMENT
                         
  2nd quarter 2020
(In millions of euros) 

Adhesive
Solutions

 

Advanced
Materials

 

Coating
Solutions

 

Intermediates

 

Corporate

 

Total    

                         
Total sales 

453

 

628

 

436

 

379

 

6

 

1.902

EBITDA  

50

 

124

 

59

 

66

 

(13)

 

286

Recurring depreciation and amortization of tangible and intangible assets  

(15)

 

(63)

 

(31)

 

(31)

 

(2)

 

(142)

Recurring operating income (REBIT) 

35

 

61

 

28

 

35

 

(15)

 

144

Depreciation and amortization related to the revaluation of tangible and intangible assets as part of the allocation of the purchase price of businesses  

(10)

 

(4)

 

(1)

 

-

 

-

 

(15)

Other income and expenses 

(26)

 

(12)

 

(3)

 

188

 

(40)

 

107

Operating income 

(1)

 

45

 

24

 

223

 

(55)

 

236

Equity in income of affiliates  

-

 

0

 

-

 

1

 

-

 

1

                         
Intangible assets and property, plant and equipment additions 

19

 

45

 

15

 

39

 

5

 

123

Of which recurring capital expenditure  

19

 

30

 

14

 

10

 

5

 

78

 
  2nd quarter 2019 *
(In millions of euros) 

Adhesive
Solutions

 

Advanced
Materials

 

Coating
Solutions

 

Intermediates

 

Corporate

 

Total    

                         
Total sales 

520

 

650

 

575

 

502

 

7

 

2.254

EBITDA  

71

 

142

 

91

 

127

 

(24)

 

407

Recurring depreciation and amortization of tangible and intangible assets  

(16)

 

(55)

 

(29)

 

(28)

 

(1)

 

(129)

Recurring operating income (REBIT) 

55

 

87

 

62

 

99

 

(25)

 

278

Depreciation and amortization related to the revaluation of tangible and intangible assets as part of the allocation of the purchase price of businesses   

(9)

 

-

 

(1)

 

-

 

-

 

(10)

Other income and expenses 

(2)

 

(7)

 

(0)

 

-

 

(2)

 

(11)

Operating income 

44

 

80

 

61

 

99

 

(27)

 

257

Equity in income of affiliates  

-

 

(1)

 

-

 

1

 

-

 

0

                         
Intangible assets and property, plant and equipment additions 

12

 

70

 

24

 

16

 

2

 

124

Of which recurring capital expenditure  

12

 

47

 

24

 

16

 

2

 

101

 
* 2019 figures have been restated in accordance with the new reporting structure announced by the Group on April 2, 2020.
INFORMATION BY SEGMENT
                     
  End of June 2020
(In millions of euros) 

Adhesive
Solutions

 

Advanced
Materials

 

Coating
Solutions

 

Intermediates

 

Corporate

 

Total    

                     
Total sales 

968

 

1.280

 

953

 

776

 

13

 

3.990

EBITDA  

119

 

246

 

124

 

134

 

(37)

 

586

Recurring depreciation and amortization of tangible and intangible assets  

(30)

 

(124)

 

(60)

 

(64)

 

(4)

 

(282)

Recurring operating income (REBIT) 

89

 

122

 

64

 

70

 

(41)

 

304

Depreciation and amortization related to the revaluation of tangible and intangible assets as part of the allocation of the purchase price of businesses  

(18)

 

(8)

 

(3)

 

-

 

-

 

(29)

Other income and expenses 

(29)

 

(18)

 

(3)

 

184

 

(41)

 

93

Operating income 

42

 

96

 

58

 

254

 

(82)

 

368

Equity in income of affiliates  

-

 

(2)

 

-

 

1

 

-

 

(1)

                         
Intangible assets and property, plant and equipment additions 

34

 

83

 

29

 

62

 

7

 

215

Of which recurring capital expenditure  

34

 

55

 

28

 

33

 

7

 

157

                     
  End of June 2019 *
(In millions of euros) 

Adhesive
Solutions

 

Advanced
Materials

 

Coating
Solutions

 

Intermediates

 

Corporate

 

Total    

                         
Total sales 

1.033

 

1.322

 

1.139

 

961

 

14

 

4.469

EBITDA  

133

 

293

 

170

 

230

 

(49)

 

777

Recurring depreciation and amortization of tangible and intangible assets  

(30)

 

(109)

 

(54)

 

(56)

 

(3)

 

(252)

Recurring operating income (REBIT) 

103

 

184

 

116

 

174

 

(52)

 

525

Depreciation and amortization related to the revaluation of tangible and intangible assets as part of the allocation of the purchase price of businesses 

(17)

 

-

 

(2)

 

-

 

-

 

(19)

Other income and expenses 

(5)

 

(11)

 

(1)

 

(3)

 

(3)

 

(23)

Operating income 

81

 

173

 

113

 

171

 

(55)

 

483

Equity in income of affiliates  

-

 

(3)

 

-

 

2

 

-

 

(1)

                         
Intangible assets and property, plant and equipment additions 

21

 

134

 

46

 

27

 

5

 

233

Of which recurring capital expenditure  

21

 

88

 

46

 

27

 

5

 

187

 
* 2019 figures have been restated in accordance with the new reporting structure announced by the Group on April 2, 2020.
CONSOLIDATED CASH FLOW STATEMENT
       
   

End of June 2020

 

End of June 2019

    
(In millions of euros)   
    
Cash flow - operating activities   
    
Net income  

198

 

327

Depreciation, amortization and impairment of assets  

422

 

316

Other provisions and deferred taxes  

54

 

(1)

(Gains)/losses on sales of long-term assets   

(245)

 

(4)

Undistributed affiliate equity earnings   

2

 

1

Change in working capital  

(26)

 

(167)

Other changes  

11

 

12

    
Cash flow from operating activities  

416

 

484

    
Cash flow - investing activities   
    
Intangible assets and property, plant, and equipment additions   

(215)

 

(233)

Change in fixed asset payables  

(55)

 

(96)

Acquisitions of operations, net of cash acquired   

(92)

 

(19)

Increase in long-term loans   

(23)

 

(20)

    
Total expenditures  

(385)

 

(368)

    
Proceeds from sale of intangible assets and property, plant and equipment   

2

 

6

Proceeds from sale of businesses, net of cash transferred  

327

 

-

Repayment of long-term loans  

37

 

16

    
Total divestitures  

366

 

22

    
Cash flow from investing activities  

(19)

 

(346)

    
Cash flow - financing activities   
    
Issuance (repayment) of shares and other equity  

7

 

3

Purchase of treasury shares  

(21)

 

(17)

Issuance of hybrid bonds  

299

 

399

Redemption of hybrid bonds  

-

 

(425)

Dividends paid to parent company shareholders  

(168)

 

(190)

Interest paid to bearers of subordinated perpetual notes  

-

 

(12)

Dividends paid to non-controlling interests  

(1)

 

(1)

Increase in long-term debt   

3

 

2

Decrease in long-term debt   

(40)

 

(515)

Increase/ decrease in short-term borrowings  

(508)

 

518

    
Cash flow from financing activities  

(429)

 

(238)

    
Net increase/(decrease) in cash and cash equivalents  

(32)

 

(100)

    
Effect of exchange rates and changes in scope  

25

 

(10)

Cash and cash equivalents at beginning of period   

1.407

 

1.441

    
Cash and cash equivalents at end of period  

1.400

 

1.331

CONSOLIDATED BALANCE SHEET
       
   

End of June 2020

 

End of December 2019

    
(In millions of euros)   
    
ASSETS  

 

   

 

Intangible assets, net  

3.365

 

3.392

Property, plant and equipment, net   

2.944

 

3.026

Equity affiliates: investments and loans   

32

 

33

Other investments   

56

 

53

Deferred tax assets  

161

 

216

Other non-current assets   

224

 

240

TOTAL NON-CURRENT ASSETS  

                                  6.782

 

6.960

   

 

 

 

Inventories   

1.006

 

                                  1.014

Accounts receivable  

1.184

 

                                  1.204

Other receivables and prepaid expenses  

183

 

184

Income tax receivables  

74

 

113

Other current financial assets  

20

 

17

Cash and cash equivalents   

1.400

 

1.407

Assets held for sale  

-

 

78

   

 

 

 

TOTAL CURRENT ASSETS  

3.867

 

4.017

TOTAL ASSETS  

10.649

 

10.977

   

 

 

 

   

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY  

 

 

 

   

 

 

 

Share capital  

767

 

766

Paid-in surplus and retained earnings   

4.663

 

4.340

Treasury shares  

(29)

 

(11)

Translation adjustments   

142

 

178

SHAREHOLDERS' EQUITY - GROUP SHARE  

5.543

 

5.273

Non-controlling interests  

51

 

51

TOTAL SHAREHOLDERS' EQUITY  

5.594

 

5.324

   

 

 

 

Deferred tax liabilities  

334

 

334

Provisions for pensions and other employee benefits  

562

 

525

Other provisions and non-current liabilities  

389

 

391

Non-current debt  

2.380

 

2.377

TOTAL NON-CURRENT LIABILITIES  

3.665

 

3.627

   

 

 

 

Accounts payable  

783

 

905

Other creditors and accrued liabilities  

352

 

366

Income tax payables  

86

 

80

Other current financial liabilities  

15

 

8

Current debt  

154

 

661

Liabilities related to assets held for sale  

-

 

6

   

 

 

 

TOTAL CURRENT LIABILITIES  

1.390

 

2.026

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY  

10.649

 

10.977

CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY

   
         
   Shares issued              Treasury shares  Shareholders'
equity - Group
share
Non-
controlling
interests
Shareholders'
equity
(In millions of euros)  Number  Amount  Paid-in
surplus
 Hybrid
bonds
 Retained
earnings
 Translation
adjustments
 Number  Amount  
At January 1, 2020  

76,624,220

 

766

 

1.266

 

694

 

2.380

 

178

 

(131.028)

 

(11)

 

5.273

51

5.324

Cash dividend  

-

 

-

 

-

 

-

 

(168)

 

-

 

-

 

-

 

(168)

(1)

(169)

Issuance of share capital  

112.256

 

1

 

6

 

-

 

-

 

-

 

-

 

-

 

7

 

7

Purchase of treasury shares  

-

 

-

 

-

 

-

 

-

 

-

 

(280.000)

 

(21)

 

(21)

-

(21)

Grants of treasury shares to employees  

-

 

-

 

-

 

-

 

(3)

 

-

 

33.124

 

3

 

0

-

0

Share-based payments  

-

 

-

 

-

 

-

 

12

 

-

 

-

 

-

 

12

-

12

Issuance of hybrid bonds  

-

 

-

 

-

 

299

 

-

 

-

 

-

 

-

 

299

-

299

Other  

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

-

-

Transactions with shareholders  

112.256

 

1

 

6

 

299

 

(159)

 

-

 

(246.876)

 

(18)

 

129

(1)

128

Net income  

-

 

-

 

-

 

-

 

197

 

-

 

-

 

-

 

197

1

198

Total income and expense recognized directly through equity  

-

 

-

 

-

 

-

 

(20)

 

(36)

 

-

 

-

 

(56)

-

(56)

Comprehensive income  

-

 

-

 

-

 

-

 

177

 

(36)

 

-

 

-

 

141

1

142

At June 30, 2020  

76,736,476

 

767

 

1.272

 

993

 

2.398

 

142

 

(377.904)

 

(29)

 

5.543

51

5.594

ALTERNATIVE PERFORMANCE INDICATORS

To monitor and analyse the financial performance of the Group and its activities, the Group management uses alternative performance indicators. These are financial indicators that are not defined by the IFRS. This note presents a reconciliation of these indicators and the aggregates from the consolidated financial statements under IFRS.

RECURRING OPERATING INCOME (REBIT) AND EBITDA

      
(In millions of euros)  

End of June 2020

 

End of June 2019

 

2nd quarter 2020

 

2nd quarter 2019

         
OPERATING INCOME  

368

 

483

 

236

 

257

- Depreciation and amortization related to the revaluation of tangible and intangible assets as part of the allocation of the purchase price of businesses   

(29)

 

(19)

 

(15)

 

(10)

- Other income and expenses  

93

 

(23)

 

107

 

(11)

RECURRING OPERATING INCOME (REBIT)  

304

 

525

 

144

 

278

- Recurring depreciation and amortization of tangible and intangible assets  

(282)

 

(252)

 

(142)

 

(129)

EBITDA  

586

 

777

 

286

 

407

        
                 
Details of depreciation and amortization of tangible and intangible assets:                
                 
(In millions of euros)  

End of June 2020

 

End of June 2019

 

2nd quarter 2020

 

2nd quarter 2019

             
Depreciation and amortization of tangible and intangible assets  

(422)

 

(316)

 

(266)

 

(144)

Of which:  Recurring depreciation and amortization of tangible and intangible assets  

(282)

 

(252)

 

(142)

 

(129)

Of which:  Depreciation and amortization related to the revaluation of assets as part of the allocation of the purchase price of businesses  

(29)

 

(19)

 

(15)

 

(10)

Of which: Impairment included in other income and expenses  

(111)

 

(45)

 

(109)

 

(5)

ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE

      
(In millions of euros)  

End of June 2020

 

End of June 2019

 

2nd quarter 2020

 

2nd quarter 2019

       
NET INCOME - GROUP SHARE  

197

 

323

 

119

 

176

- Depreciation and amortization related to the revaluation of tangible and intangible assets as part of the allocation of the purchase price of businesses   

(29)

 

(19)

 

(15)

 

(10)

- Other income and expenses  

93

 

(23)

 

107

 

(11)

- Other income and expenses - Non-controlling interests  

-

 

-

 

0

 

-

- Taxes on depreciation and amortization related to the revaluation of assets as part of the allocation of the purchase price of businesses  

7

 

5

 

4

 

3

- Taxes on other income and expenses  

(64)

 

3

 

(67)

 

2

- One-time tax effects  

-

 

-

 

-

 

-

ADJUSTED NET INCOME  

190

 

357

 

90

 

192

- Weighted average number of ordinary shares  

76,457,621

 

76,214,216

 

-

   
- Weighted average number of potential ordinary shares  

76,667,395

 

76,608,099

 

-

   
ADJUSTED EARNINGS PER SHARE (€)  

2.49

 

4.68

 

1.18

 

2.52

DILUTED ADJUSTED EARNINGS PER SHARE (€)  

2.48

 

4.66

 

1.18

 

2.51

RECURRING CAPITAL EXPENDITURE

      
(In millions of euros)  

End of June 2020

 

End of June 2019

 

2nd quarter 2020

 

2nd quarter 2019

    
INTANGIBLE ASSETS AND PROPERTY, PLANT, AND EQUIPMENT ADDITIONS  

215

 

233

 

123

 

124

- Exceptional capital expenditure  

57

 

38

 

44

 

20

- Investments relating to portfolio management operations   

-

 

-

 

-

 

-

- Capital expenditure with no impact on net debt   

1

 

8

 

1

 

3

RECURRING CAPITAL EXPENDITURE  

157

 

187

 

78

 

101

FREE CASH FLOW

      
(In millions of euros)  

End of June 2020

 

End of June 2019

 

2nd quarter 2020

 

2nd quarter 2019

             
Cash flow from operating activities  

416

 

484

 

313

 

242

+ Cash flow from investing activities  

(19)

 

(346)

 

217

 

(176)

NET CASH FLOW  

397

 

138

 

530

 

66

- Net cash flow from portfolio management operations  

147

 

(25)

 

242

 

(24)

FREE CASH FLOW  

250

 

163

 

288

 

90

             
The net cash flow from portfolio management operations corresponds to the impact of acquisition and divestment operations.    
In 2020, a tax rate of 32% was applied to the capital gain related to the Functional Polyolefins business divestment    

WORKING CAPITAL

    
(In millions of euros)  

End of June 2020

 

End of December 2019

       
Inventories   

1.006

 

1.014

+ Accounts receivable  

1.184

 

1.204

+ Other receivables including income taxes  

257

 

297

+ Other current financial assets  

20

 

17

- Accounts payable  

783

 

905

- Other liabilities including income taxes  

438

 

446

- Other current financial liabilities  

15

 

8

WORKING CAPITAL  

1.231

 

1.173

CAPITAL EMPLOYED

    
(In millions of euros)  

End of June 2020

 

End of December 2019

       
Goodwill, net  

1.875

 

1.917

+ Intangible assets (excluding goodwill), and property, plant and equipment, net  

4.434

 

4.501

+ Investments in equity affiliates  

32

 

33

+ Other investments and other non-current assets  

280

 

293

+ Working capital  

1.231

 

1.173

CAPITAL EMPLOYED  

7.852

 

7.917

NET DEBT

    
(In millions of euros)  

End of June 2020

 

End of December 2019

       
Non-current debt  

2.380

 

2.377

+ Current debt  

154

 

661

- Cash and cash equivalents  

1.400

 

1.407

NET DEBT  

1.134

 

1.631

+ Hybrid bonds  

1.000

 

700

NET DEBT AND HYBRID BONDS  

2.134

 

2.331